Ads
related to: rna interference mechanism
Search results
Insider Sell: CEO Christopher Anzalone Sells 57,755 Shares of Arrowhead Pharmaceuticals Inc
GuruFocus.com via Yahoo Finance· 9 months agoOn September 18, 2023, Christopher Anzalone, the CEO of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR),...
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday
Motley Fool· 1 year agoWhat happened Shares of clinical-stage biotech company Arrowhead Pharmaceuticals (NASDAQ: ARWR) were...
Nobel Prize in Medicine: 1901-Present
Live Science via Yahoo News· 2 years agoIllustration of microscope and blood cells. Physiology or medicine was the third prize area Alfred Nobel mentioned in his will laying out his wishes for...
Arrowhead Pharmaceuticals Inc CEO Christopher Anzalone Sells 9,952 Shares
GuruFocus.com via Yahoo Finance· 5 months agoArrowhead Pharmaceuticals Inc (NASDAQ:ARWR) CEO, Christopher Anzalone, sold 9,952 shares of the...
Insider Sell: Chief Discovery/Trans Medicine James Hamilton Sells 6,000 Shares of Arrowhead ...
GuruFocus.com via Yahoo Finance· 2 months agoJames Hamilton, Chief Discovery and Translational Medicine Officer at Arrowhead Pharmaceuticals Inc...
Bank of America Says the S&P 500 Will Hit a New Record High in 2024 — Here Are 2 Stocks to Play That...
TipRanks via Yahoo Finance· 6 months agoThis has been a good year for stocks, no doubt about that. The S&P 500 has gained 19% year-to-date,...
New Drug Could Control Blood Pressure With Just 2 Doses Per Year
Verywell Health via Yahoo News· 10 months agoA small clinical study showed that a new RNA-targeted medication lowered blood pressure for up to...
U.S. FDA panel backs expanded use of Alnylam's gene silencing drug
Reuters via Yahoo News· 9 months agoThe FDA panel voted 9 to 3 that the benefits of the drug, patisiran, outweigh its risks for treating...
WAVE Life Sciences Reports First Quarter 2024 Financial Results
GuruFocus.com via Yahoo Finance· 1 month agoRevenue: Reported at $12.54 million for Q1 2024, falling short of the estimated $22.95 million. Net Loss: Increased to $31.56 million in Q1 2024 from $27.41 million in Q1 2023, exceeding the ...
Bank of America Says These 3 Healthcare Stocks Have up to ~160% Upside Potential
TipRanks via Yahoo Finance· 5 months agoNo matter what your preference in the stock market, the nature of the game is always going to...